[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100565271":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":19,"centralContacts":23,"locations":29,"responsibleParty":47,"collaborators":10,"id":49,"slug":50,"hasResults":51,"nctId":52,"briefTitle":53,"officialTitle":53,"acronym":10,"eligibilityCriteria":54,"healthyVolunteers":51,"sex":55,"minAge":56,"maxAge":10,"enrollmentInfo":57,"targetDuration":10,"studyType":60,"phases":10,"briefSummary":61,"conditions":62,"keywords":10,"overallStatus":32,"whyStopped":10,"lastUpdateSubmitDate":65,"lastUpdatePostDateStruct":66,"startDateStruct":69,"completionDateStruct":71,"leadSponsor":73,"locationsCount":74},{"fullName":5,"class":6},"Mayo Clinic","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Observational",null,"Patients undergo blood sample collection and have their medical records reviewed on study.",[13],"Other: Non-Interventional Study",[15],{"type":6,"name":16,"description":17,"armGroupLabels":18,"otherNames":10},"Non-Interventional Study","Non-interventional study",[9],[20],{"name":21,"affiliation":5,"role":22},"Nadine Norton, PhD","PRINCIPAL_INVESTIGATOR",[24],{"name":25,"role":26,"phone":27,"phoneExt":10,"email":28},"Clinical Trials Referral Office","CONTACT","855-776-0015","mayocliniccancerstudies@mayo.edu",[30],{"facility":31,"status":32,"city":33,"state":34,"zip":35,"country":36,"countryCode":37,"cosmosGeoPoint":38,"geoPoint":43,"contacts":44},"Mayo Clinic in Florida","RECRUITING","Jacksonville","Florida","32224-9980","United States","US",{"type":39,"coordinates":40},"Point",[41,42],-81.65565,30.33218,{"lat":42,"lon":41},[45,46],{"name":25,"role":26,"phone":27,"phoneExt":10,"email":28},{"name":21,"role":22,"phone":10,"phoneExt":10,"email":10},{"type":48,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100565271","using-induced-pluripotent-stem-cells-to-model-cancer-therapy-related-adverse-events-100565271",false,"NCT06640010","Using Induced-Pluripotent Stem Cells to Model Cancer Therapy-Related Adverse Events","Inclusion Criteria:\n\n* Any patient \\>= 18 years of age\n* Previously treated, planned or currently receiving any potentially toxic cancer therapy including but not limited to chemotherapy, targeted and immunotherapies\n\nExclusion Criteria:\n\n* Inability on the part of the patient to understand the informed consent or be compliant with the protocol","ALL","18 Years",{"count":58,"type":59},30,"ESTIMATED","OBSERVATIONAL","This study is being done to find out if patient blood samples can be used to perform individualized modeling of cancer therapy-related side effects.",[63,64],"Hematopoietic and Lymphatic System Neoplasm","Malignant Solid Neoplasm","2026-06-18",{"date":67,"type":68},"2026-06-23","ACTUAL",{"date":70,"type":68},"2025-02-12",{"date":72,"type":59},"2027-12-15",{"name":5,"class":6},1]